The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice

References

• Amable L. (2016). Cisplatin resistance and opportunities for precision medicine. Pharmacol Res 106:27–36.
   PubMed Web of Science ®Google Scholar
• Arnesano F, Losacco M, Natile G. (2013). An updated view of cisplatin transport. Eur J Inorg Chem 2013:2701–11.
   Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.
   PubMed Web of Science ®Google Scholar
• Chang C-E, Hsieh C-M, Chen L-C, et al. (2018). Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer. Drug Delivery 25: 632–43.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin 66: 115–32.
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. (2010). In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm 387: 129–38.
   PubMed Web of Science ®Google Scholar
• Chereddy KK, Payen VL, Préat V. (2018). PLGA: From a classic drug carrier to a novel therapeutic activity contributor. J Control Release 289:10–3.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Committee (2015): Pharmacopoeia of the People’s Republic of China. The Medicine Science and Technology Press of China.
   Google Scholar
• Dasari S, Tchounwou P. Bernard (2014). Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–78.
   PubMed Web of Science ®Google Scholar
• Dong W, Zhang L, Niu Y, et al. (2013). A stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy. Expert Opin Drug Deliv 10:559–71.
   PubMed Web of Science ®Google Scholar
• Dong Y, Chin S-F, Blanco E, et al. (2009). Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res 15: 131–9.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Fathy M. (2009). Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. Saudi Pharm J 17: 217–25.
   PubMedGoogle Scholar
• Florea A-M, Büsselberg D. (2011). Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3:1351–71.
   PubMedGoogle Scholar
• Galluzzi L, Vitale I, Michels J, et al. (2014). Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5:e1257.
   PubMed Web of Science ®Google Scholar
• Gao L, Xia L, Zhang R, et al. (2017). Enhanced antitumor efficacy of poly(d,l-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice. Drug Des Dev Ther 11:3065–75.
   PubMed Web of Science ®Google Scholar
• Li C, Cheng L, Zhang Y, et al. (2010). Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants. Int J Pharm 386:23–9.
   PubMed Web of Science ®Google Scholar
• Mahvi DA, Liu R, Grinstaff MW, et al. (2018). Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin 68:488–505.
   PubMed Web of Science ®Google Scholar
• Manohar S, Leung N. (2018). Cisplatin nephrotoxicity: a review of the literature. J Nephrol 31:15–25.
   PubMed Web of Science ®Google Scholar
• Mitchell DA, Cui X, Schmittling RJ, et al. (2011). Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood 118:3003–12.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (2018). NCCN clinical practice guidelines in clinical practice guidelines in oncology: bone cancer. Version 2 Available online at https://www.nccn.org/professionals/physician_gls/default.aspx.
   Google Scholar
• Shahid F, Farooqui Z, Khan F. (2018). Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies. Eur J Pharmacol 827:49–57.
   PubMed Web of Science ®Google Scholar
• Shikanov A, Shikanov S, Vaisman B, et al. (2011). Cisplatin tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Chemother Res Pract 2011:175054.
   PubMedGoogle Scholar
• Solano AGR, de Fátima Pereira A, Pinto FCH, et al. (2013). Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants. AAPS PharmSciTech 14:890–900.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang X, Zhang L, et al. (2015). Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release. Drug Deliv 22:389–99.
   PubMed Web of Science ®Google Scholar
• Weinberg BD, Blanco E, Gao J. (2008). Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 97:1681–702.
   PubMed Web of Science ®Google Scholar
• Wolinsky JB, Colson YL, Grinstaff MW. (2012). Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 159:14–26.
   PubMed Web of Science ®Google Scholar
• Xu Y, Kim C-S, Saylor DM, Koo D. (2017). Polymer degradation and drug delivery in PLGA-based drug-polymer applications: a review of experiments and theories. J Biomed Mater Res 105:1692–716.
   Web of Science ®Google Scholar
• Yang J, Ju Z, Dong S. (2016). Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer. Drug Deliv 24:792–9.
   PubMed Web of Science ®Google Scholar
• Yue Z, Cao Z. (2016). Current strategy for cisplatin delivery. Curr Cancer Drug Target 16:480–8.
   PubMed Web of Science ®Google Scholar
• Zong S, Wang X, Yang Y, et al. (2015). The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice. Eur J Pharm Biopharmaceutics 93:127–35.
   PubMed Web of Science ®Google Scholar